期刊文献+

Ⅳ型登革病毒中国株LD34在KMB17细胞上的适应性及其生物学特性 被引量:1

Adaptability of Dengue-Ⅳ virus LD34 strain in KMB17 cells and biological characteristics of adapted strain
原文传递
导出
摘要 目的研究Ⅳ型登革病毒中国株LD34在人胚肺二倍体细胞KMB17上的传代适应性及其生物学特性。方法将Ⅳ型登革病毒中国株LD34在C6/36细胞上扩增,并采用微量细胞病变法测定病毒的感染性滴度。以2.0 MOI的病毒接种KMB17细胞传代培养,筛选KMB17细胞适应株,并进行培养条件的优化。将Ⅳ型登革病毒中国株LD34 KMB17细胞适应株连续传10代,测定病毒的感染性滴度,免疫荧光法检测病毒的抗原性,RT-PCR法扩增登革病毒的特异性基因。结果筛选出的Ⅳ型登革病毒中国株LD34在KMB17细胞上的最佳培养条件为病毒接种MOI 0.4,培养基血清浓度5%;其感染KMB17细胞后可产生明显的细胞病变(CPE),连续传10代,病毒滴度达7.75 CCID50/ml;第10代病毒的抗原性呈阳性;第10代病毒能扩增出511 bp的登革病毒特异性基因和393 bp的Ⅳ型登革病毒特异性基因。结论获得了Ⅳ型登革病毒中国株LD34 KMB17细胞适应株,病毒保持了原始毒株的基本生物学特性,且具有较好的抗原性。 Objective To investigate the adaptability of Dengue-Ⅳ virus LD34 strain,isolated in China,in KMB17 cells and the biological characteristics of adapted strain.Methods Dengue-Ⅳ LD34 strain was propagated in C6 / 36 cells and determined for infectivity,then inoculated to KMB17 cells at a MOI of 2.0 for subculture,based on which the adapted strain was screened,and the culture condition was optimized.The adapted strain was subcultured in KMB17 cells for 10 passages,then determined for infectious titer by microtitrimetry,and for antigenicity by IFA,from which the specific gene was amplified by RT-PCR.Results The optimal MOI and serum concentration in medium for culture of the screened adapted strain were 0.4 and 5% respectively.The adapted strain caused obvious CPE of KMB17 cells,and reached a titer of 7.75 CCID50 / ml after subculture for 10 passages.The virus of passage 10 was positive for antigenicity,from which a Dengue virus-specific gene fragment at a length of 511 bp and a Dengue virus-Ⅳ-specific gene fragment at a length of 393 bp were amplified.Conclusion A KMB17 cells-adapted Dengue-Ⅳ virus LD34 strain was obtained,which showed the primary biological characteristics of original strain and good antigenicity.
出处 《中国生物制品学杂志》 CAS CSCD 2012年第9期1135-1138,共4页 Chinese Journal of Biologicals
基金 云南省科技厅社会发展科技计划项目(2011CA016) 中国医学科学院病原生物学研究所中央级公益性科研院所科研业务费项目(2009IPB102) 中国医学科学院医学生物学研究所引进人才项目(IMB2009RC01) 云南省自然科学基金项目(2009ZC187M)
关键词 登革病毒 人胚肺二倍体细胞 适应性 生物学特性 Dengue virus Human embryonic lung diploid cells Adaptability Biological characteristics
  • 相关文献

参考文献11

  • 1Lopez AD,Mathers CD,Ezzati M,et al.Global burden of diseaseand risk factors[M].Oxford:Oxford University Press,2006.
  • 2Halstead SB.Neutralization and antibody-dependent enhancementof dengue viruses[J].Adv Virus Res,2003,60(1):421-467.
  • 3Guy B,Almond JW.Towards a dengue vaccine:progress to dateand remaining challenges[J].Comp Immunol Microbiol Infect Dis,2008,31(2-3):239-252.
  • 4Simasathien S,Thomas SJ,Watanaveeradej V,et al.Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children[J].Am J Trop Med Hyg,2008,78(3):426-433.
  • 5谢忠平,宋霞,全文琦,熊秋霞,段维国,丁雪凤,王燕,邹静如.细胞内快速连续传代培养甲肝病毒的研究[J].现代预防医学,2006,33(7):1089-1090. 被引量:5
  • 6Yoshida K,Nasu Y,Shitami N,et al.A novel convenient method for high bacteriophage titer assay[J].Nucleic Acids Symp Ser(Oxf),2009,53(1):315-316.
  • 7马应霞,易山,张光明,张永欣,张标,孙茂盛.轮状病毒P[8]G1株在KMB17细胞上的适应性及其免疫原性[J].中国生物制品学杂志,2010,23(9):942-945. 被引量:6
  • 8Stadler C,Skogs M,Brismar H,et al.A single fixation protocolfor proteome-wide immunofluorescence localization studies[J].JProteomics,2010,73(6):1067-1078.
  • 9Ramanathan MP,Kuo YC,Selling BH,et al.Development of anovel DNA SynConTM tetravalent dengue vaccine that elicits im-mune responses against four serotypes[J].Vaccine,2009,27(46):6444-6453.
  • 10Chao DY,King CC,Wang WK,et al.Strategically examiningthe full-genome of dengue virus type 3 in clinical isolates revealsits mutation spectra[J].Virol J,2005,2(1):72-81.

二级参考文献14

  • 1赵慧,段鸿元,李晓萸,赵卓,康晓平,秦鄂德.细胞密度和感染复数对SARS病毒在Vero细胞中增殖的影响[J].生物技术通讯,2005,16(3):274-275. 被引量:10
  • 2刘馨,张光明,李鸿钊,谢天宏,孙茂盛.表达轮状病毒VP4抗原的重组腺病毒对新生小鼠的被动免疫保护作用[J].中国生物制品学杂志,2007,20(1):33-36. 被引量:8
  • 3何海洋,李晋涛,费蕾,姜曼,牟芝蓉,付晓兰,唐艳,段召军,吴玉章.轮状病毒不同毒株感染宿主细胞的感染效力研究[J].免疫学杂志,2007,23(3):255-259. 被引量:3
  • 4Siitari H. Dual-label time-resolved fluoroimmunoassay for the simultaneous detection of adenovirus and rotavirus in faeces [J]. J Virol Methods, 1990, 28 (2): 179-187.
  • 5Atherly D, Dreibelbis R, Parashar LID, et al. Rotavirus vaccination: cost-effectiveness and impact on child mortality in developing countries [J]. J Infect Dis, 2009, 200 (Suppl 1):S28-S38.
  • 6Barrett PN, Mundt W, Kistner O, et al. Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines [ J ]. Expert Rev Vaccines, 2009, 8 ( 5 ) : 607-618.
  • 7Ranheim T, Mathis PK, Joelsson DB, et al. Development and application of a quantitative RT-PCR potency assay for a pentavalent rotavirus vaccine(RotaTeq) [J]. J Virol Methods, 2006, 131 (2): 193-201.
  • 8Suzuki H, Konno T,Numazaki Y, et ol. Three different serotypes of human rotavirus determined using an interference test with coxsackievirus B 1 [J]. J Med Virol, 1984, 13 (1):41-44.
  • 9李琦涵,姜莉.病毒与细胞相互作用的生物学意义[A].病毒感染的分子生物学[M].北京:化学工业出版社,2004,95-143
  • 10Anderson DA,Bruce C,Ross.et al.Restricted Replication of Hepatitis A virus in cell culture:Encapasidation of viral RNA Depletes the pool of RNA Available for Replication[J].J Virol,1988,62 (11):4201-4206.

共引文献9

同被引文献14

  • 1谢忠平,宋霞,全文琦,熊秋霞,段维国,丁雪凤,王燕,邹静如.细胞内快速连续传代培养甲肝病毒的研究[J].现代预防医学,2006,33(7):1089-1090. 被引量:5
  • 2Kyle J L, Harris E. Global spread and persistence of dengue. Annu Rev Microbiol,2008,62: 71-92.
  • 3Kuhn R J,Zhang W, Rossmann M G, et al. Structure of dengue virus : implications for flavivirus organization, maturation, and fusion. Cell,2002,108(5 ) :717-725.
  • 4Guy B, Almond J W. Towards a dengue vaccine : Progress to date and remaining challenges. Comp Immun Microbiol Infect Dis, 2008,31 ( 2-3 ) :239-252.
  • 5Yoshida K, Nasu Y, Shitami N, et al. A novel convenient method for high bacteriophage titer assay. Nucleic Acids Syrup Ser (Oxf) ,2009,53:315-316.
  • 6Stadler C, Skogs M, Brismar H. A single fixation protocol for proteome-wide immunofluoreseenee localization studies. Journal of Proteomies, 2010,73 (6) : 1067-1078.
  • 7Webster D P, Farrar J, Rowland-Jones S. Progress towards a dengue vaccine. The lancetlnfect Dis,2009,9( 1 ) :678-687.
  • 8Sabchareon A, Lang J, Chanthavanich P, et al. Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses. Am J Trop Med Hyg,2002,66(3) :264-272.
  • 9Ramanathan M P, Kuo Y C, Selling B H, et al. Development of a novel DNA SynConTM tetravalent dengue vaccine that elicits immune responses against four serotypes. Vaccine, 2009, 27: 6444-6453.
  • 10Bente D A, Melkus M W, Gareia J V, et al. Dengue fever in humanized NOD/SCID mice. J Virol,79 (21) :13797-13799.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部